
Can GLP-1 medications pay for themselves? We examine a new CVS Health analysis on medical savings and obesity treatment costs.A new CVS Health study suggests that medical savings from reduced hospitalizations and emergency visits could offset the cost of GLP-1 medications for insurers within three years. We break down these findings to see what the data actually proves regarding long-term affordability and why this could shift the conversation around insurance coverage for patients.Beyond the study, we are covering an FDA inspection of Strive Pharmacy regarding sterile compounding practices and environmental monitoring. We also look at new Zepbound discounts for eligible patients and an expansion of the NovoCare support platform. Understanding these pharmaceutical industry developments is essential for navigating access to treatment.Subscribe for weekly obesity medicine news and clinical trial updates, and let us know in the comments: do you think this study will influence how your employer approaches insurance coverage?🔗 **CONNECT WITH ON THE PEN**All our links, community resources, and social platforms: https://linktr.ee/manonthemounjaro📰 News and analysis: https://onthepen.com📺 Subscribe for breaking GLP-1 news, clinical trial updates, pharmaceutical industry developments, and patient advocacy.**SOURCES:**CVS Health GLP-1 Study: https://www.cvshealth.com/content/dam/enterprise/cvs-enterprise/pdfs/2026/GLP1_Whitepaper.pdfFDA Form 483, Strive Pharmacy: https://www.fda.gov/media/196833/downloadNovoCare Announcement: https://www.prnewswire.com/news-releases/novo-launches-the-new-novocare-free-support-program-connects-people-with-wegovy-in-addition-to-home-delivery-everyday-support-wellness-partners-and-rewards-302941304.html*Disclaimer: Dave Knapp is not a medical professional. This content is for informational and educational purposes only and is not medical advice. Observational study findings do not establish causation. FDA Form 483 observations are not final agency determinations of violations.*#GLP1 #Mounjaro #Zepbound #Wegovy #Ozempic #CVSHealth #NovoNordisk #EliLilly #ObesityMedicine #OnThePen
Weitere Episoden von „On The Pen GLP-1 News“



Verpasse keine Episode von “On The Pen GLP-1 News” und abonniere ihn in der kostenlosen GetPodcast App.








